Autoimmunity-inducing metals (Hg, Au and Ag) modulate mast cell signaling, function and survival

Current Pharmaceutical Design

Volumn 17, Issue 34, 2011, Pages 3805-3814

  Suzuki, Yoshihiro ^a   Inoue, Toshio ^a   Ra, Chisei ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Apoptosis; Mitochondria; Necrosis; Nitric oxide; Ros

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA N ACETYLHEXOSAMINIDASE; CALCIUM CHANNEL L TYPE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GOLD; HISTAMINE; HYDROGEN PEROXIDE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; MERCURIC CHLORIDE; MERCURY; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; REACTIVE OXYGEN METABOLITE; SEROTONIN; SILVER; SILVER NANOPARTICLE; SILVER NITRATE; STAT6 PROTEIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; VASCULOTROPIN;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA BINDING; ENZYME ACTIVATION; HISTAMINE RELEASE; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SEROTONIN RELEASE; SIGNAL TRANSDUCTION;

EID: 83455238445     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798357917     Document Type: Review

References (84)

1. Eneström S, Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol 1995; 106: 180-203.
2. Druet E, Sapin C, Günther E, Feingold N, Druet P. Mercuric chloride- induced anti-glomerular basement membrane antibodies in the rat: genetic control. Eur J Immunol 1977; 7: 348-351.
3. Monestier M, Losman MJ, Novick KE, Aris JP. Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J Immunol 1994;152: 667-675.
4. Hultman P, Eneström S, Turley SJ, Pollard KM. Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice. Clin Exp Immunol 1994; 96: 285-291.
5. Hultman P, Ganowiak K, Turley SJ, Pollard KM. Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clin Immunol Immunopathol 1995; 77: 291-297.
6. Griem P, Gleichmann E. Metal ion induced autoimmunity. Curr Opin Immunol 1995; 7: 831-838.
7. Bagenstose LM, Salgame P, Monestier M. Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. Environ Health Perspect 1999; 107: 807-810.
8. Hansson M, Abedi-Valugerdi M. Xenobiotic metal-induced autoimmunity: mercury and silver differentially induce antinucleolar autoantibody production in susceptible H-2s, H-2q and H-2f mice. Clin Exp Immunol 2003; 131: 405-414.
9. Sapin C, Druet E, Druet P. Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin Exp Immunol 1997; 28: 173-179.
10. Goldman M, Druet P, Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemicallyinduced autoimmunity. Immunol Today 1991; 12: 223-227.
11. Mathieson PW, Thiru S, Oliveira DB. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest 1992; 67: 121-129.
12. Havarinasab S, Johansson U, Pollard KM, Hultman P. Gold causes genetically determined autoimmune and immunostimulatory responses in mice. Clin Exp Immunol 2007; 150: 179-188.
13. Havarinasab S, Pollard KM, Hultman P. Gold- and silver-induced murine autoimmunity--requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin Exp Immunol 2009; 155: 567-76.
14. Robinson CJ, Balazs T, Egorov IK. Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice. Toxicol Appl Pharmacol 1986; 86: 159-169.
15. Schuhmann D, Kubicka-Muranyi M, Mirtschewa J, Gunther J, Kind P, Gleichmann E. Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. J Immunol 1990; 145: 2132-2139.
16. Hultman P, Johansson U, Turley SJ, Lindh U, Eneström S, Pollard KM. Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. FASEB J 1994; 8: 1183-1190.
17. Aris JP, Blobel G. Cdna cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera. Proc Natl Acad Sci USA 1991; 88: 931-935.
18. Okano Y, Steen VD, Medsger TA Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 95-100.
19. Arnett FC, Fritzler MJ, Ahn C, Holian A. Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin). J Rheumatol 2000; 27: 405-410.
20. Rowley B, Monestier M. Mechanisms of heavy metal-induced autoimmunity. Mol Immunol 2005; 42: 833-838.
21. Mirtcheva J, Pfeiffer C, De Bruijn JA, Jacquesmart F, Gleichmann E. Immunological alterations inducible by mercury compounds. III. H-2A acts as an immune response and H-2E as an immune suppression locus for HgCl2-induced antinucleolar autoantibodies. Eur J Immunol 1989; 19: 2257-2261.
22. Hultman P, Bell LJ, Eneström S, Pollard KM. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol. 1992; 65: 98-109.
23. Hultman P, Bell LJ, Eneström S, Pollard KM. Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin Immunol Immunopathol. 1992; 68: 9-20.
24. Abedi-Valugerdi M, Möller G. Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. Int Immunol 2000; 12: 1425-1430.
25. Hultman P, Nielsen JB. The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity. J Autoimmun 2001; 17: 27-37.
26. Hultman P, Ganowiak K, Turley SJ, Pollard KM. Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clin Immunol Immunopathol. 1995; 77: 291-297.
27. Galli SJ, Kalesnikoff J, Grimbaldeston MA., Piliponsky AM, Williams CMM, Tsai M. Mast cells as tunable effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23: 749-786.
28. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 2004; 114: 21-27.
29. Rottem M, Mekori YA. Mast cells and autoimmunity. Autoimmun Rev 2005; 4: 21-27.
30. Kiely PD, Thiru S, Oliveira DB. Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest 1995; 73: 284-293.
31. Kiely PD, Pecht I, Oliveira DB. Mercuric chloride-induced vasculitis in the Brown Norway rat: αβT cell-dependent and - independent phases: role of the mast cell. J Immunol 1997; 159: 5100-5106.
32. Wolfreys K, Oliveira DB. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol 1997; 27: 297-306
33. 2- sensitive pathways including L-type calcium channels. Free Radic Biol Med 2011; 50: 1417-1428.
34. Suzuki Y, Yoshimaru T, Yamashita K, Matsui T, Yamaki M, Shimizu K. Exposure of RBL-2H3 mast cells to Ag+ induces cell degranulation and mediator release. Biochem Biophys Res Commun 2001; 283: 707-714.
35. Suzuki Y, Yoshimaru T, Matsui T, Ra C. Silver activates calcium signals in rat basophilic leukemia-2H3 mast cells by a mechanism that differs from the FcεRI-activated response. J Immunol 2002; 169: 3954-3962.
36. 2+ influx. Free Radic Biol Med 2006; 40: 1949-59.
37. 2+-dependent mast cell death induced by Ag (I) via cardiolipin oxidation and ATP depletion. J Leukoc Biol 2009; 86: 167-179.
38. 2+ influx and mast cell activation: role of a nitric oxide synthase-independent pathway. J Leukoc Biol 2009; 86: 1365-1375.
39. Schedle A, Samorapoompichit P, Füreder W. et al. Metal ioninduced toxic histamine release from human basophils and mast cells. J Biomed Mater Res 1998; 39: 560-567.
40. Dastych J, Walczak-Drzewiecka A, Wyczolkowska J, Metcalfe DD. Murine mast cells exposed to mercuric chloride release granule- associated N-acetyl-β-D-hexosaminidase and secrete IL-4 and TNF-α. J Allergy Clin Immunol 1999;103: 1108-1114.
41. Strenzke N, Grabbe J, Plath KE, Rohwer J, Wolff HH, Gibbs BF. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils. Toxicol Appl Pharmacol. 2001;174: 257-263.
42. Kempuraj D, Asadi S, Zhang B. et al. Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation 2010; 20: 865-867.
43. Wu Z, Turner DR, Oliveira DB. IL-4 gene expression up-regulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. Int Immunol 2001; 13: 297-304.
44. Yang W, Lee S, Lee J, Bae Y, Kim D. Silver nanoparticle-induced degranulation observed with quantitative phase microscopy. J Biomed Opt 2010; 15: 045005.
45. Gomez G, Gonzalez-Espinosa C, Odom S. et al. Impaired FcεRIdependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol 2005; 175: 7602-7610.
46. 2+ channels. Mol Immunol 2009; 46: 1267-1277.
47. 2+ signaling, cell activation and cell survival in immune cells. Mol Immunol 2010; 47: 640-648.
48. Walczak-Drzewiecka A, Wyczółkowska J, Dastych J. C-Jun Nterminal kinase is involved in mercuric ions-mediated interleukin-4 secretion in mast cells. Int Arch Allergy Immunol 2005; 136: 181-190.
49. Li-Weber M, Salgame P, Hu C. et al. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. J Immunol 1998; 161: 1380-1389.
50. Hehner SP, Li-Weber M, Giaisi M. et al, Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells. J Immunol 2000; 164: 3829-3836.
51. Li-Weber M, Giaisi M, Treiber MK, Krammer PH. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur J Immunol 2002; 32: 2401-8.
52. Frossi B, De Carli M, Daniel KC, Rivera J, Pucillo C. Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway. Eur J Immunol 2003; 33: 2168-2177.
53. Frossi B, Rivera J, Hirsch E, Pucillo C. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 2007; 178: 2549-2555.
54. Hernandez-Hansen V, Bard JD, Tarleton CA. et al. Increased expression of genes linked to FcεRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells. J Immunol 2005; 175: 7880-7888.
55. Heneberg P, Dráberová L, Bambousková M, Pompach P, Dráber P. Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts. J Biol Chem 2010; 285: 12787-12802.
56. Wu Z, Pearson A, Oliveira D. Characterization of cis-regulatory elements conferring mercury-induced interleukin-4 gene expression in rat mast cells: a role for signal transducer and activator of transcription 6 and TATA box binding sites. Immunology 2009; 127: 530-538.
57. Savignac M, Badou A, Delmas C. et al. Gold is a T cell polyclonal activator in BN and LEW rats but favors IL-4 expression only in autoimmune prone BN rats. Eur J Immunol 2001; 31: 2266-2276.
58. Suzuki Y, Yoshimaru T, Matsui T. et al. FcεRI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals. J Immunol 2003; 171: 6119-127.
59. Suzuki Y, Yoshimaru T, Inoue T, Niide O, Ra C. Role of oxidants in mast cell activation. Chem Immunol Allergy 2005; 87: 32-42.
60. Swindle EJ, Metcalfe DD. The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol Rev 2007; 217: 186-205.
61. Rivera. Molecular adapters in FcεRI signaling and the allergic response. Curr Opin Immunol 2002; 14: 688-693.
62. Di Capite JL, Bates GJ, Parekh AB. Mast cell CRAC channel as a novel therapeutic target in allergy. Curr Opin Allergy Clin Immunol. 2011; 11: 33-38
63. Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 1999; 276: G315-G321.
64. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 2002; 129: 4-10.
65. Eastmond NC, Banks EM, Coleman JW. Nitric oxide inhibits IgEmediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J Immunol 1997; 159: 1444-1450.
66. Davis BJ, Flanagan BF, Gilfillan AM, Metcalfe DD, Coleman JW. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J Immunol 2004; 173: 6914-6920.
67. Sekar Y, Moon TC, Muñoz S, Befus AD. Role of nitric oxide in mast cells. Immnol Res 2005; 33: 223-229.
68. Gilchrist M, McCauley SD, Befus AD. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood. 2004; 104: 462-469.
69. Gilchrist M, Hesslinger C, Befus AD. Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells. J Biol Chem 2003; 278: 50607-50614.
70. Inoue T, Suzuki Y, Yoshimaru T, Ra C. Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol- 3-kinase- Akt-endothelial nitric oxide synthase pathway. J Leukoc Biol 2008; 83: 1218-1229.
71. 2+ channel activation and survival in RBL-2H3 mast cells. Biochim Biophys Acta 2010; 1803: 372-385.
72. Swindle EJ, Metcalfe DD, Coleman JW. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J Biol Chem 2004; 279: 48751-4879.
73. Werner ER, Werner-Felmayer G. Biopterin analogues: novel nitric oxide synthase inhibitors with immunosuppressive action. Curr Drug Metab 2002; 3: 119-121.
74. Thomas DD, Miranda KM, Colton CA, Citrin D, Espey MG, Wink DA. Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation. Antioxid Redox Signal 2003; 5: 307-317.
75. Lacza Z, Kozlov AV, Pankotai E. et al. Mitochondria produce reactive nitrogen species via an arginine-independent pathway. Free Radic Res 2006; 40: 369-378.
76. Suzuki KG, Fujiwara TK, Sanematsu F, Iino R, Edidin M, Kusumi, A. GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single- molecule tracking study 1. J Cell Biol 2007; 177: 717-730.
77. Ghannadan M, Baghestanian M, Wimazal F. et al. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 1998; 111: 689-695.
78. Ortonne N, Ram-Wolff C, Giustiniani J. Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160. J Invest Dermatol 2011; 131: 916-924.
79. Elishmereni M, Levi-Schaffer F. CD48: A co-stimulatory receptor of immunity. Int J Biochem Cell Biol. 2011; 43: 25-28.
80. Dráberová L, Dráber, P. Thy-1-mediated activation of rat basophilic leukemia cells does not require co-expression of the highaffinity IgE receptor. Eur J Immunol 1995; 25: 2428-2432.
81. Heneberg P, Lebduska P, Dráberová L, Korb J, Dráber P. Topography of plasma membrane microdomains and its consequences for mast cell signaling. Eur J Immunol 2006; 36: 2795- 27806.
82. Tolarová H, Dráberová L, Heneberg P. Dráber, P. Involvement of filamentous actin in setting the threshold for degranulation in mast cells. Eur J Immunol 2004; 34: 1627-1636.
83. Rana SV. Metals and apoptosis: recent developments. J Trace Elem Med Biol 2008; 22: 262-284.
84. Norberg E, Orrenius S, Zhivotovsky B. Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochem Biophys Res Commun 2010; 396: 95-100